Ferredoxin-NADP Reductase
"Ferredoxin-NADP Reductase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the oxidation and reduction of FERREDOXIN or ADRENODOXIN in the presence of NADP. EC 1.18.1.2 was formerly listed as EC 1.6.7.1 and EC 1.6.99.4.
Descriptor ID |
D005287
|
MeSH Number(s) |
D08.811.682.667.076
|
Concept/Terms |
Ferredoxin-NADP Reductase- Ferredoxin-NADP Reductase
- Ferredoxin NADP Reductase
- Reductase, Ferredoxin-NADP
- NADPH-Ferredoxin Reductase
- NADPH Ferredoxin Reductase
- Reductase, NADPH-Ferredoxin
- Adrenodoxin Reductase
- Reductase, Adrenodoxin
- Iron-Sulfur Protein Reductase
- Iron Sulfur Protein Reductase
- Protein Reductase, Iron-Sulfur
- Reductase, Iron-Sulfur Protein
|
Below are MeSH descriptors whose meaning is more general than "Ferredoxin-NADP Reductase".
Below are MeSH descriptors whose meaning is more specific than "Ferredoxin-NADP Reductase".
This graph shows the total number of publications written about "Ferredoxin-NADP Reductase" by people in UAMS Profiles by year, and whether "Ferredoxin-NADP Reductase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ferredoxin-NADP Reductase" by people in Profiles over the past ten years.
-
Lyu C, Webber DM, MacLeod SL, Hobbs CA, Li M. Gene-by-gene interactions associated with the risk of conotruncal heart defects. Mol Genet Genomic Med. 2020 01; 8(1):e1010.